Tìm kiếm
Sản phẩm
Cộng đồng
Thị trường
Tin tức
Nhà môi giới
Thêm nữa
VI
Bắt đầu
Cộng đồng
/
Ý tưởng
/
SRZN a Penny biotech LONG
Surrozen, Inc.
Giá lên
SRZN a Penny biotech LONG
Theo AwesomeAvani
Theo dõi
Theo dõi
Cập nhật
23 thg 2
1
Chúc mừng
Chúc mừng
21 thg 2
SRZN has had good momentum. It has no revenues. Clinical trials but a lot of cash. SRZN has
advanced trials underway for a product to treat alcoholic hepatitis presumably settling it down
before it becomes irreversible cirrhosis (only for patients who are alcohol-free) and also useful
for liver metabolic disorders from a genetic basis.
SRZN has been trending up for a week with a bit of a pause in the middle of it. It picked up
60% of its price while breaking out through the anchored VWAP lines and the volume profile.
The far greater market is the former.
It is priced at 90 or more off it's all-time high of about $160. IF it picks up hype from the
last clinical trial getting a report and a calendared review by the, SRZN could reach for that
all time high. This is speculative and risky as are most biotechnology penny stocks. They are
trading news and potential not current net revenues. A small position with room in the stop
loss for the average range and volatility is best. This is a typical high risk higher potential
reward type of trade.
21 thg 2
Giao dịch đang hoạt động
One week chart was uploaded in error but does show the all-time high. Linked here
is the 15-minute version
22 thg 2
Giao dịch đang hoạt động
AI indicator suggests that price might be topping out later this morning. It has been
a good trade. looking to see if it reverses .
23 thg 2
Đóng lệnh: đạt mục tiêu
Reversal arrived and closed in profit.
biotechnology
biotechstocks
clinicalstudy
fdaapproval
LABU
Oscillators
pennystock
Volatility
Volume
XBI
Thông báo miễn trừ trách nhiệm
Thông tin và ấn phẩm không có nghĩa là và không cấu thành, tài chính, đầu tư, kinh doanh, hoặc các loại lời khuyên hoặc khuyến nghị khác được cung cấp hoặc xác nhận bởi TradingView. Đọc thêm trong
Điều khoản sử dụng
.